← Open Payments lookup

LINDSEY TETEN: Open Payments

NPI 1164838967 · NEBRASKA CITY, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,145 in 81 payments from 16 companies in 2025. Trend: 2023 $837 · 2024 $1,299 · 2025 $1,145

Food & beverage: $1,144Education: $1
CompanyPaymentsAmount
ABBVIE INC.24$340
Otsuka America Pharmaceutical, Inc.16$202
Vanda Pharmaceuticals Inc.13$145
HARMONY BIOSCIENCES LLC5$85
Neurocrine BioSciences, Inc.3$46
Takeda Pharmaceuticals U.S.A., Inc.3$46
Neos Therapeutics, LP3$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$36
Axsome Therapeutics, Inc.2$35
Collegium Pharmaceutical, Inc.2$33

Products named: VRAYLAR, REXULTI, HETLIOZ, WAKIX, FANAPT, ABILIFY MAINTENA, ABILIFY ASIMTUFII, INGREZZA.

Industry payments across NE — which companies pay providers there.